Multiple epiphyseal dysplasia type 1 is a rare inherited bone and joint condition that affects how the ends of bones develop. It usually becomes noticeable in childhood, and early signs of Multiple epiphyseal dysplasia type 1 can include joint pain, a waddling walk, stiff joints, and slower growth. In plain terms, it means the joints may wear down earlier than expected, so many living with Multiple epiphyseal dysplasia type 1 develop early arthritis over time. Not everyone will have the same experience. Multiple epiphyseal dysplasia type 1 is usually lifelong but not usually life-threatening, and treatment focuses on pain relief, physical therapy, activity changes, and sometimes orthopedic surgery such as joint replacement.
How many people live with Multiple epiphyseal dysplasia type 1?
Multiple epiphyseal dysplasia as a whole is estimated to affect at least about 820,000 people worldwide (GeneReviews, 2018; United Nations, 2024); because type 1 is thought to be the most common form and may make up around 70% of diagnosed cases, that suggests roughly 570,000 people worldwide are living with type 1, but this is an estimate rather than a direct count (GeneReviews, 2018). In the United States, the same estimate works out to at least about 34,000 people with multiple epiphyseal dysplasia overall (GeneReviews, 2018; U.S. Census Bureau, 2024), with roughly 24,000 living with type 1 by the same method, again as an estimate rather than a direct count (GeneReviews, 2018).
Overview
Multiple epiphyseal dysplasia type 1Symptoms
Multiple epiphyseal dysplasia type 1 mainly affects the joints and bones. Many living with multiple epiphyseal dysplasia type 1 have joint pain, stiffness, a waddling walk, and short fingers, with signs often first noticed in early childhood.
Outlook and prognosis
Multiple epiphyseal dysplasia type 1 often means lifelong joint pain, stiffness, and early arthritis, but many stay active with pain care, physical therapy, and sometimes surgery. Life span is usually typical. Symptoms and mobility can vary widely.
Causes and risk factors
Multiple epiphyseal dysplasia type 1 is caused by a change in the COMP gene, often inherited from one affected parent, though it can begin new in a child. Lifestyle does not cause it, but body weight can worsen joint strain.
Genetic influences
Genetics are central to multiple epiphyseal dysplasia type 1. It is caused by changes in the COMP gene, and different genetic variants can affect how early symptoms of multiple epiphyseal dysplasia type 1 begin and how severe they are.
Diagnosis
Diagnosis of Multiple epiphyseal dysplasia type 1 usually starts with clinical features such as joint pain, a waddling walk, or short fingers, along with X-rays showing changes at the ends of the bones. Genetic tests can confirm the diagnosis.
Treatment and drugs
Multiple epiphyseal dysplasia type 1 is treated by easing pain and protecting joints. Physical therapy, activity changes, supportive shoes or braces, and pain medicine can help. Some people need orthopedic follow-up or surgery for hip problems.
Symptoms
Multiple epiphyseal dysplasia type 1 usually shows up in the joints that take the most load, so everyday problems often involve walking, running, climbing stairs, or standing for long periods. The early features of Multiple epiphyseal dysplasia type 1 often include aching hips or knees, stiffness, and a waddling walk. Features can vary from person to person and may become more noticeable with growth and with earlier joint wear over time.
Aching in the hips, knees, or ankles is common, especially after running, sports, or a longer walk. In Multiple epiphyseal dysplasia type 1, this pain often starts in childhood and may ease with rest.
Joints may feel tight after sitting still, first thing in the morning, or after a busy day. This can make stairs, squatting, or getting up from the floor feel awkward.
Some people walk with a side-to-side or waddling pattern. This may make longer distances slower and more tiring.
Hips and knees may not bend or straighten fully. People with Multiple epiphyseal dysplasia type 1 may notice this when kneeling, sitting cross-legged, or getting in and out of a car.
How people usually first notice Multiple epiphyseal dysplasia type 1?
Multiple epiphyseal dysplasia type 1 is often first noticed when a child who seemed well at birth starts to develop joint pain, tires more easily with walking or running, or has a subtle waddling gait in early childhood. Many living with this condition are first recognized because growth seems a bit different over time, with mild short stature or stiffness in the hips, knees, or ankles, while X-rays show that the ends of the bones near the joints, called the epiphyses, are developing unevenly. In some families, the first signs of multiple epiphyseal dysplasia type 1 come to light only after a parent, sibling, or other relative is diagnosed, because early symptoms can be mild and easy to mistake for ordinary growing pains.
Types of Multiple epiphyseal dysplasia type 1
No distinct types of Multiple epiphyseal dysplasia type 1 are widely recognized.
Can I slow down the onset of symptoms?
No, at this time there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms in multiple epiphyseal dysplasia type 1, because it is an inherited condition that affects how the ends of bones and joints develop. Staying at a healthy weight, using joint-friendly activity, and getting physical therapy when needed may help reduce stress on the joints and make symptoms easier to manage, but these steps have not been shown to prevent the condition or stop symptoms from starting. There is no proven preventive treatment, but regular follow-up with an orthopedic specialist can help catch joint problems early, and while that cannot guarantee a later onset, it can still make a real difference in comfort and daily function.
What genetics can tell you about symptoms
Genetics can give some clues about symptoms in multiple epiphyseal dysplasia type 1, but it usually cannot predict the exact day-to-day experience for one person. Changes in the COMP gene are linked to this condition, and different variants can influence how early joint pain, stiffness, limping, or hip and knee problems begin and how severe they become, although there is overlap from one person to another. In many living with this condition, genetics helps explain the overall pattern of cartilage and bone growth problems, while other factors still shape how symptoms unfold over time.
Causes and risk factors
In multiple epiphyseal dysplasia type 1, sore hips, knees, or ankles often start with a change in the COMP gene. This gene change is usually inherited from a parent, but it can also happen for the first time in a child. Having an affected parent is the main risk factor, and not everyone with the same risk develops the condition. Growth, body weight, and repeated joint stress can influence when symptoms begin and how severe they feel. Sports, work, or daily activity do not cause multiple epiphyseal dysplasia type 1, but they can make early symptoms of multiple epiphyseal dysplasia type 1 more noticeable.
What are the most common causes or risk factors?
Multiple epiphyseal dysplasia type 1 is mainly caused by a change in the COMP gene, which helps cartilage support the joints and helps the ends of bones develop in the usual way. The biggest risk factor is having a parent with this condition, because a child can develop it after inheriting one changed copy of the gene from either parent, although it can also happen for the first time in someone with no family history. There are no known lifestyle or environmental risk factors, so it is not caused by diet, exercise, or an injury.
Environmental and biological risk factors
When people look into risk factors for multiple epiphyseal dysplasia type 1, it can be reassuring to know that clear non-genetic triggers have not been established. Doctors often group risks into internal (biological) and external (environmental). For this condition, current evidence does not point to reliable environmental or other non-genetic biological factors that raise the chance of it occurring.
No specific chemical, pollutant, radiation exposure, or other outside factor has been proven to increase the likelihood of multiple epiphyseal dysplasia type 1. Current evidence does not show a consistent environmental pattern behind this condition.
No consistent non-genetic biological factor has been confirmed to raise the chance of multiple epiphyseal dysplasia type 1. Common pregnancy and birth circumstances have not been established as causes.
Genetic risk factors
When joint pain, stiffness, and early wear-and-tear start in childhood or the teen years, the genetic causes of multiple epiphyseal dysplasia type 1 usually trace back to one gene called COMP. Multiple epiphyseal dysplasia type 1 is most often inherited in families in an autosomal dominant pattern, which means one changed copy of the gene can be enough to cause it. In some families, the change starts for the first time in one child, and symptoms can vary even among relatives who carry the same change.
COMP gene: For multiple epiphyseal dysplasia type 1, the main known genetic cause is a harmful change in the COMP gene. This gene helps support cartilage, so a change in it can affect how the ends of bones develop and how joints hold up over time.
Autosomal dominant: Multiple epiphyseal dysplasia type 1 usually follows an autosomal dominant inheritance pattern. If a parent carries the gene change, each child has a 1 in 2, or 50%, chance of inheriting it.
Family history: Having a parent or close relative with multiple epiphyseal dysplasia type 1 raises the chance that it runs in the family. Even within the same family, the condition may be milder in some relatives and more noticeable in others.
New change: Sometimes the COMP gene change happens for the first time in a child and is not inherited from either parent. When this happens, there may be no family history even though the condition is still genetic.
Lifestyle risk factors
Lifestyle habits do not cause Multiple epiphyseal dysplasia type 1, but they can influence joint pain, mobility, fatigue, and the pace of secondary joint damage. For many families asking how lifestyle affects Multiple epiphyseal dysplasia type 1, the key issues are reducing mechanical stress on abnormal joints and supporting long-term function. Daily choices around activity, body weight, nutrition, and pain management can make symptoms easier or harder to control.
Extra body weight increases load across the hips, knees, and ankles that are already vulnerable in Multiple epiphyseal dysplasia type 1. Over time, this can worsen pain, limit walking tolerance, and speed up early osteoarthritis.
Regular low-impact activity such as swimming, cycling, or water exercise can help maintain muscle support around affected joints. Better strength and conditioning may improve mobility and reduce stiffness without the repeated pounding of high-impact training.
Frequent jumping, sprinting, contact sports, or heavy lifting can place excessive stress on irregular joint surfaces. In some people, this may trigger more pain flares, swelling, and faster wear of weight-bearing joints.
Targeted strengthening and flexibility work can improve joint alignment, balance, and movement patterns in people with Multiple epiphyseal dysplasia type 1. Poor conditioning may leave joints less supported and make everyday activities more painful or tiring.
Risk prevention
Multiple epiphyseal dysplasia type 1 cannot usually be prevented because it is an inherited condition present from birth. For many living with multiple epiphyseal dysplasia type 1, prevention is really about lowering the risk of joint damage, pain, falls, and other complications over time. Different people need different prevention strategies—there’s no single formula. Care often works best when daily habits, physical therapy, and regular bone and joint follow-up all fit together.
If multiple epiphyseal dysplasia type 1 runs in your family, genetic counseling can help you understand inheritance and family planning options. This cannot prevent the condition in someone who already has it, but it can clarify reproductive choices and testing.
Paying attention to early symptoms of multiple epiphyseal dysplasia type 1, such as joint pain, stiffness, or a child tiring quickly with walking, can lead to earlier support. Early orthopedic review may help reduce avoidable joint strain and slow later wear and tear.
Regular low-impact movement such as swimming, cycling, or walking on even ground can help keep joints mobile and muscles strong. High-impact sports, repeated jumping, and heavy joint loading may increase pain or speed joint damage in some people with multiple epiphyseal dysplasia type 1.
Keeping weight in a healthy range lowers stress on hips, knees, and ankles. Even if you can’t remove all risks, prevention can reduce their impact.
Can you prevent Multiple epiphyseal dysplasia type 1?
No, multiple epiphyseal dysplasia type 1 usually cannot be prevented, because it is caused by a gene change that is present from birth and affects how bones and joints develop. Healthy habits are still important for overall health, but they do not stop this condition from happening. If it runs in your family, genetic counseling before pregnancy may help you understand the chances of passing it on, but it cannot guarantee prevention.
Transmission
Multiple epiphyseal dysplasia type 1 is not infectious, so it cannot be passed from one person to another through close contact, coughing, sex, food, or blood. Instead, the genetic transmission of Multiple epiphyseal dysplasia type 1 usually happens from parent to child.
This form is most often inherited in an autosomal dominant pattern, which means a parent with the condition has a 1 in 2, or 50%, chance of passing the altered gene to each child. Sometimes Multiple epiphyseal dysplasia type 1 happens for the first time in a family because of a new genetic change, so a child can be born with it even when neither parent is known to have it.
When to test your genes
Consider genetic testing for multiple epiphyseal dysplasia type 1 if there is a family history, or if a child has early hip or knee pain, a waddling gait, stiffness, or mild short stature. Testing can confirm the diagnosis, guide orthopedic monitoring, and help with family planning.
Diagnosis
Multiple epiphyseal dysplasia type 1 is often first suspected when a child has joint pain, tires more quickly with walking, or seems to develop a slightly unusual gait over time. Doctors usually begin by looking at growth, hip and knee movement, and the pattern of symptoms, because the diagnosis of multiple epiphyseal dysplasia type 1 often depends on both visible features and confirmatory testing. In many living with this condition, the changes can be subtle at first, so diagnosis may take time rather than happening in a single visit.
Doctors review symptoms such as joint pain, stiffness, tiring easily, or waddling when walking. They also look at height, limb alignment, and how the hips, knees, and ankles move to see whether the pattern fits multiple epiphyseal dysplasia type 1.
A detailed family and health history can help because this condition can run in families. Similar childhood joint problems, early arthritis, or relatives with a comparable walk may provide important clues.
Imaging of the hips, knees, ankles, and sometimes other joints can show epiphyses, the growing ends of bones, that are small, irregular, or developing unevenly. These imaging findings are often central to the genetic diagnosis of multiple epiphyseal dysplasia type 1.
A blood or saliva test can look for a change in the COMP gene, which is the usual cause of type 1. Finding this variant can confirm the diagnosis and help distinguish it from other bone growth conditions with similar symptoms.
How is Multiple epiphyseal dysplasia type 1 diagnosed?
Multiple epiphyseal dysplasia type 1 is usually diagnosed by putting together a child or adult's symptoms, family history, and imaging tests, especially X-rays that show the ends of the bones near the joints are developing in an unusual way. Doctors often suspect it when someone has joint pain, a stiff or uneven walk, or early wear-and-tear arthritis along with these X-ray changes. A genetic test can then help confirm the diagnosis by finding a change in the COMP gene, but it is usually used alongside the exam and imaging rather than by itself.
Stages of Multiple epiphyseal dysplasia type 1
Multiple epiphyseal dysplasia type 1 does not have defined progression stages. That is because it is a genetic bone and joint condition that is usually identified by its pattern of growth and joint changes, rather than by a set sequence of stages over time. Doctors usually start with a conversation about joint pain, stiffness, walking changes, and the early symptoms of Multiple epiphyseal dysplasia type 1, then look at X-rays to see how the ends of the bones and the joints are developing. Follow-up is usually based on symptoms, physical exams, and repeat imaging when needed, especially if hip, knee, or ankle problems begin to affect daily life.
Outlook and prognosis
The outlook for people with multiple epiphyseal dysplasia type 1 is usually good in terms of life expectancy, which is generally considered normal because the condition does not typically affect major internal organs. Prognosis is mainly shaped by the severity of joint involvement, with many people developing chronic hip, knee, ankle, or shoulder pain, stiffness, fatigue with activity, and early-onset osteoarthritis that can worsen over time. Symptoms often begin in childhood, but the degree of disability varies widely, and some individuals remain relatively active while others eventually need orthopedic procedures such as osteotomies or joint replacement in adulthood. Short stature, mild gait abnormalities, and reduced endurance may affect quality of life, but intelligence and overall survival are not usually impaired. Mortality is not thought to be increased directly by the disorder itself, although long-term musculoskeletal complications can have a substantial impact on mobility, pain burden, and daily functioning.
Long-term effects
For many people, Multiple epiphyseal dysplasia type 1 affects the joints over many years, especially the hips, knees, and ankles. It often becomes more noticeable with age as stiffness, aching, and reduced joint movement start to affect walking, exercise, work, or other daily routines. It’s important to remember that long-term doesn’t always mean progressive, but the long-term effects of Multiple epiphyseal dysplasia type 1 can vary widely from one person to another.
Ongoing aching or stiffness in weight-bearing joints is common, especially after activity or later in the day. Many living with Multiple epiphyseal dysplasia type 1 find that pain builds gradually rather than appearing all at once.
The joints can wear down sooner than expected, leading to early osteoarthritis in adulthood. This may cause swelling, grinding, and a smaller range of motion over time.
Hip, knee, or ankle involvement can change the way someone walks and may make stairs, long distances, or uneven ground harder. Some may develop a limp or tire more quickly during everyday movement.
Stiff joints can make it harder to squat, kneel, bend deeply, or keep up with sports and other physical activities. For many, this can mean small adjustments in how they move through the day.
How is it to live with Multiple epiphyseal dysplasia type 1?
Living with multiple epiphyseal dysplasia type 1 often means growing up with joints that wear down too early, so many people have chronic hip or knee pain, stiffness, easy fatigue, and trouble with long walks, running, stairs, or standing for long periods. Some also have a shorter adult height or a different gait, and for many this can mean planning daily life around pacing, physical therapy, pain care, and sometimes orthopedic surgery when arthritis becomes more severe. The effects reach beyond the person living with the condition, because family members, partners, teachers, and coworkers may need to adapt activities, transportation, chores, or work expectations, but with the right support many people build active, independent lives that protect their joints and energy.
Treatment and drugs
Multiple epiphyseal dysplasia type 1 does not have a cure, so treatment focuses on easing pain, protecting the joints, and helping people stay as active as possible in daily life. For many people, treatment begins with small daily steps, such as physical therapy, low-impact exercise, supportive shoes or braces, and keeping weight in a healthy range to reduce stress on hips, knees, and ankles. Multiple epiphyseal dysplasia type 1 often also involves pain relief medicines, and a doctor may monitor joint changes over time because early symptoms of Multiple epiphyseal dysplasia type 1 can lead to stiffness, limping, and early arthritis. If joint damage becomes more severe, treatment for Multiple epiphyseal dysplasia type 1 may include orthopedic surgery to improve joint shape, correct alignment, or replace a badly worn joint. Because symptoms and joint problems can vary from one person to another, regular follow-up with specialists helps tailor treatment over time.
Can you cure Multiple epiphyseal dysplasia type 1?
No, there is no cure for multiple epiphyseal dysplasia type 1 right now. Treatment can help manage joint pain and stiffness, support movement, and address problems like early wear and tear in the joints with physical therapy, pain relief, activity changes, braces, and sometimes surgery. Care is based on each person’s symptoms, since this condition can affect people in different ways.
Non-drug treatment
Living with Multiple epiphyseal dysplasia type 1 often means managing joint pain, stiffness, and fatigue in day-to-day life, especially with walking, stairs, sports, or long periods on your feet. Because this condition affects how the ends of bones and joints develop, non-drug care usually focuses on protecting joints, keeping movement as comfortable as possible, and supporting independence. Managing this condition often works best when care is tailored to age, symptoms, and which joints are most affected. Some people need only therapy and activity changes, while others may also need braces or surgery over time.
Physical therapy can help maintain joint movement, strengthen supporting muscles, and improve balance and walking. For many, treatment begins not at the pharmacy, but with a plan that builds strength without overloading painful hips, knees, or ankles.
Low-impact exercise such as swimming, cycling, or water therapy can help people with Multiple epiphyseal dysplasia type 1 stay active with less joint strain. You may need to try more than one strategy before finding the right mix of movement, rest, and pacing for painful days.
Shoe inserts, supportive footwear, braces, or sometimes mobility aids can improve alignment and reduce stress on sore joints. Some non-drug options are delivered by specialists, such as orthotists or physical therapists, who fit devices to make walking safer and more comfortable.
Occupational therapy can make daily tasks easier by teaching joint-protection techniques and suggesting tools for dressing, bathing, school, or work. This can be especially helpful when the early symptoms of Multiple epiphyseal dysplasia type 1 include hand discomfort, fatigue, or trouble with repeated movements.
Your genes may have an impact on how drugs work for you
Right now, there is no well-proven evidence that the gene change linked to multiple epiphyseal dysplasia type 1 changes how the usual medicines for joint pain or swelling work. Even so, people with this condition can still respond differently to pain relievers, anti-inflammatory medicines, or medicines used around surgery, and that can happen for many reasons, including other inherited differences, age, body size, liver or kidney health, and other medicines they take. For many living with multiple epiphyseal dysplasia type 1, this simply means treatment may need some trial and adjustment, especially if a pain medicine does not help enough or causes side effects like stomach upset or unusual sleepiness.
Pharmacological treatments
For many living with Multiple epiphyseal dysplasia type 1, medicines are mainly used to ease joint pain and stiffness so daily tasks like walking, climbing stairs, or getting through school or work feel more manageable. There is no medication that fixes the underlying cartilage and bone growth change in Multiple epiphyseal dysplasia type 1, so treatment focuses on symptoms and is tailored to age, pain level, and which joints are affected. Not everyone responds to the same medication in the same way.
Acetaminophen is often used first for mild to moderate pain in Multiple epiphyseal dysplasia type 1, especially when the main problem is aching without much swelling. It can help with day-to-day discomfort, but it does not reduce joint inflammation.
Nonsteroidal anti-inflammatory drugs such as ibuprofen, naproxen, and celecoxib may help when Multiple epiphyseal dysplasia type 1 causes pain along with stiffness or swelling. These medicines can irritate the stomach, raise blood pressure, or affect the kidneys in some people, so a doctor may suggest the lowest helpful dose.
Pain-relieving gels or creams such as topical diclofenac may be useful for sore knees, ankles, or other joints close to the skin. They may ease local pain with less whole-body exposure than pills, which can matter for people needing regular pain treatment for Multiple epiphyseal dysplasia type 1.
Corticosteroid injections are sometimes used for a particularly painful joint when symptoms flare and other medicines are not enough. Sometimes medicines are taken short-term for symptom flares, while longer-term use is limited because repeated injections can have downsides for joint tissues.
Genetic influences
When multiple epiphyseal dysplasia type 1 appears in a family, there is usually a clear genetic reason: a change in the COMP gene, which helps cartilage support growing joints. This specific type is inherited in an autosomal dominant pattern, meaning one changed copy of the gene is enough to cause the condition. It’s natural to ask whether family history plays a role. If a parent has the COMP gene change, each child has a 50% chance of inheriting it, although some people develop multiple epiphyseal dysplasia type 1 because the change happened for the first time in them. Even within the same family, the condition can look different, with some relatives having early symptoms of multiple epiphyseal dysplasia type 1 such as joint pain or stiffness, while others have milder problems for years. Genetic testing can confirm the diagnosis and help families understand who else may be at risk.
Is Multiple epiphyseal dysplasia type 1 genetic?
Genetics are central to multiple epiphyseal dysplasia type 1. It is caused by changes in the COMP gene, and different genetic variants can affect how early symptoms of multiple epiphyseal dysplasia type 1 begin and how severe they are.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal part of human biology and are common among people in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
In multiple epiphyseal dysplasia type 1, genetics matter most because the gene change helps confirm the diagnosis and gives doctors a clearer idea of how the joints may be affected over time. The condition is usually caused by a change in the COMP gene, which affects cartilage and joint development, so treatment for multiple epiphyseal dysplasia type 1 focuses on managing pain, protecting joints, and treating movement problems rather than correcting the gene itself. Not every difference in response is genetic, but for this condition there is no well-established medicine that specifically targets the underlying genetic change.
In day-to-day care, pain relievers or anti-inflammatory drugs are chosen mainly based on symptoms, age, stomach and kidney health, and other medicines, not on a known COMP-specific drug response. Genetic testing can still be useful because it may help avoid unnecessary tests, guide monitoring for early arthritis, and support decisions about physical therapy, bracing, or orthopedic surgery if joint damage becomes more severe. Even with the same gene pattern, people can have different symptoms, so treatment is usually tailored to how much pain, stiffness, or limited movement someone is actually living with.
Interactions with other conditions
For many living with Multiple epiphyseal dysplasia type 1, the biggest day-to-day issue is that joint pain and stiffness can overlap with other bone and joint problems, especially early osteoarthritis. Having more than one diagnosis can make symptoms feel harder to untangle, since hip, knee, or ankle pain may come from the underlying skeletal condition, from wear-and-tear arthritis, or from both at the same time. Some people with Multiple epiphyseal dysplasia type 1 may also develop changes in walking, reduced activity, and muscle weakness over time, which can add strain to the joints and make back pain or spine problems more noticeable. In children and teens, the early symptoms of Multiple epiphyseal dysplasia type 1 can sometimes resemble other causes of limping, growing pains, or sports injuries, so doctors usually look carefully at the pattern over time. If obesity is also present, the extra load on weight-bearing joints can worsen pain and mobility limits, although this is not unique to Multiple epiphyseal dysplasia type 1. Because symptoms can overlap with more common joint diseases, regular follow-up helps doctors separate what is due to the genetic condition itself and what may need separate treatment.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Multiple epiphyseal dysplasia type 1?
Multiple epiphyseal dysplasia type 1 can look a lot like other conditions that affect bone and joint growth, especially other inherited bone conditions such as pseudoachondroplasia, mild forms of spondyloepiphyseal dysplasia, or other types of multiple epiphyseal dysplasia. It can also be mistaken for Perthes disease, a childhood hip disorder, or for juvenile arthritis because these can also cause joint pain, stiffness, limping, and trouble keeping up with physical activity. Doctors usually tell them apart by looking at growth patterns, family history, and X-rays.
History
Long before doctors had modern imaging or genetic testing, families were often the first to notice the pattern: a child who seemed healthy overall but tired easily with walking, had stiff hips or knees, or developed joint pain much earlier than expected. In people living with multiple epiphyseal dysplasia type 1, these day-to-day problems helped shape the earliest medical descriptions, because the condition often affects how the ends of bones grow and how joints develop over time.
By the early 20th century, doctors began recognizing that some children with short stature, joint pain, or an unusual gait had a distinct skeletal condition rather than a more general bone disease. It was first described in the medical literature as a disorder involving several epiphyses, the growing ends of bones near the joints, which is where the name “multiple epiphyseal dysplasia” comes from. As X-rays became more widely available, specialists could see that the changes were centered around these growth areas, helping separate multiple epiphyseal dysplasia from other causes of hip pain, knee problems, and early arthritis in children and young adults.
Over time, doctors learned that multiple epiphyseal dysplasia was not the same in every family or every child. Some may have milder symptoms and be diagnosed only after repeated joint complaints, while others show early symptoms of multiple epiphyseal dysplasia type 1 in childhood, such as hip discomfort, stiff joints, or slower growth. This growing understanding mattered because it showed that the condition can vary a lot, even when the overall pattern is similar.
Later research linked multiple epiphyseal dysplasia type 1 to an underlying genetic cause, which helped explain why it can run in families and why the joint changes often follow a recognizable pattern. That shift, from describing symptoms and X-ray findings to understanding the biology behind them, made diagnosis more accurate and improved counseling for families. Today, the history of multiple epiphyseal dysplasia type 1 is a good example of how careful observation, better imaging, and genetics gradually turned a confusing set of childhood joint and growth problems into a clearly recognized condition.